Skip to content
Screener

Asset turnover at other companies

CareDx logo
CareDxCDNA
0.9×+0.2×
LivaNova logo
LivaNovaLIVN
0.6×0.0×
SRT
Strata Critical MedicalSRTA
0.9×+0.2×
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
0.0×
ICU Medical logo
ICU MedicalICUI
0.5×0.0×
Stereotaxis logo
StereotaxisSTXS
0.6×0.0×

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.78B-31.3%
Enterprise value$2.73B-26.6%
P/E16.2×-40.3×
P/S4.4×-3.2×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026. Open the filing →

Filed
May 5, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206453

FAQ

What is TransMedics Group, Inc.'s asset turnover?
TransMedics Group, Inc. (TMDX) reported asset turnover of 0.6× in Q1 2026.
How has TransMedics Group, Inc.'s asset turnover changed year-over-year?
TransMedics Group, Inc.'s asset turnover decreased by 10.5% year-over-year, from 0.6× to 0.6×.
What is the long-term trend for TransMedics Group, Inc.'s asset turnover?
Over 5 years (2020 to 2025), TransMedics Group, Inc.'s asset turnover has grown at a 26.5% compound annual growth rate (CAGR), from 0.2× to 0.6×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about TransMedics Group, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude